NEW! WeightWatchers RxFlexFundTM unlocks pharma-direct pricing and predictable GLP-1 cost sharing for employers. Click Here


Outcomes that matter start here
Individualized experiences — all on one platform
Our full-spectrum weight management platform flexes to meet individual needs — whether GLP-1s are part of the plan or not — boosting engagement, controlling costs, and improving health outcomes.
Real challenges, real-life results
Delivering a weight management platform that meets your organization’s objectives and employee expectations can be a challenging balancing act. We partner with you to achieve measurable, meaningful results.

54.7%
Average monthly engagement among members1
5.4%
Average weight loss at six months for Behavioral Program only2
21%
Average body weight loss in 12 months with GLP-1 medications3
4X ROI
GLP-1 companion: Weight Watchers Clinic + Behavioral Program4
Individualized experiences for everyone
Today’s Weight Watchers delivers science-backed, tech-forward weight management pathways that flex — and scale — to fit your needs.
Behavioral
Tailored nutrition and lifestyle guidance to support weight loss and beyond-the-scale outcomes.
+ Specialized experiences that meet individualized needs, including:
Diabetes
Tailored nutrition specifically designed for people living with diabetes to help them lose weight and lower blood glucose levels

GLP-1 Success
Support for members taking GLP-1 medications for weight loss, focusing on nutrient-dense food and activity targets.
Behavioral + Clinic
Concierge clinical weight care that integrates a wide formulary of medications, including GLP-1s, with behavioral weight management for personalized support.
Full Behavioral Program, plus:
Virtual clinic with 24/7 access to obesity-trained specialists
Evidence-based prescribing protocols and medication management for a wide formulary, including GLP-1s and other anti-obesity medications
Individual support from registered dietitians and specialists for medication adherence
Real-time data trends for members and population reporting for employers
Partnership that moves the needle
We have the experience to tackle your challenges — and we show up with proven solutions.

Control costs
How to navigate the costs of weight management — whether you cover GLP-1s or not
What sets us apart
Over 60+ years as a pioneer in weight management? Absolutely.
A science-led approach that makes us the #1 doctor-recommended weight-loss program?10 Of course.
Successful partnerships with 300+ employers and health plans based on collaboration and trust. Definitely.

Outcome-driven programs aligned with the latest research and backed by 180+ published studies, including 40+ randomized controlled trials.

Personalized coaching and 200+ community groups offering guidance, support, and accountability – available 24/7.

Tech-forward innovation powering digital tools and resources accessed through our award-winning app, including easy-to-use tracking tools, an AI-powered food scanner, and more.

Real-life success:
69% member engagement
Grab our latest case study to see our long-standing partnership with Indiana University Health in action.
Ready to see how it all comes together?
Our full-spectrum platform flexes to align with your strategy — supporting your population, your benefits objectives, and what comes next.
Let’s talk strategy


2 Based on an ongoing 12-week WW randomized controlled trial among 101 members. This analysis included 46 members at 8 weeks who were prescribed Naltrexone and Bupropion. Study to be completed in 2025. Apolzan JW, LaRose JG, Anton SD, Beyl RA, Greenway FL, Wickham III EP, Lanoye A, Harris MN, Martin CK, Bullard T, Foster GD. A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic control. Nutrition & Diabetes. 2023 Apr 6;13(1):3.
3 Based on internal data for 348 WW Clinic members prescribed compounded semaglutide as of the end of their first month. Compounded drug products have not been approved by the FDA, or reviewed by the FDA for safety, effectiveness, or quality. See important safety information. Thorpe K, Toles A, Shah B, Schneider J, Bravata DM. Weight Loss-Associated Decreases in Medical Care Expenditures for Commercially Insured Patients With Chronic Conditions. J Occup Environ Med. 2021 Oct 1;63(10):847-851. doi: 10.1097/JOM.0000000000002296. PMID: 34138824; PMCID: PMC8478295.
4 Employees with obesity may have higher loss of work productivity than those with normal weight, Endocrine Society, June 2023.
5 Medications require a prescription. Not all customers will medically qualify.
* Based on a 2023 survey by Cerner Enviza of 500 doctors who recommend weight loss programs to patients.


